檜垣 篤
   Department     ,
   Position  
Article types 原著
Language English
Peer review Peer reviewed
Title Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
Journal Formal name:Magn Reson Imaging
Abbreviation:Magn Reson Imaging
Domestic / ForeginForegin
Volume, Issue, Page 30(5),689-693頁
Author and coauthor Higaki Atsushi, Tamada Tsutomu, Sone Teruki, Kanki Akihiko, Sato Tomohiro, Tanimoto Daigo, Higashi Hiroki, Ito Katsuyoshi
Publication date 2012/06
Summary The objective was to clarify the clinical factors that might affect the degree of hepatic parenchymal enhancement at gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) imaging. The presence or absence of chronic liver disease (P=.002), ascites (P=.005) and splenomegaly (P=.027), and the values of prothrombin activity (P=.008), total bilirubin (T-Bil) (P=.001), albumin (P=.001), aspartate aminotransferase (AST) (P=.002) and cholinesterase (P=.007) were significantly correlated with the RE of liver parenchyma at 20 min HP. Among these parameters, increases of T-Bil (P=.011 to .028) and AST (P=.018 to .049) were predictors of decreased hepatic parenchymal enhancement. Hepatic parenchymal enhancement of Gd-EOB-DTPA was affected by various clinical parameters. Impaired hepatobiliary enhancement may be predicted by routine biochemical tests, such as T-Bil and AST.